Compositions and methods for producing human milk oligosaccharides

US12559732B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12559732-B2
Application numberUS-202117999017-A
CountryUS
Kind codeB2
Filing dateMay 18, 2021
Priority dateMay 19, 2020
Publication dateFeb 24, 2026
Grant dateFeb 24, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides compositions and methods related to the production of human milk oligosaccharides (HMOs). In particular, the present disclosure provides compositions and methods for converting lactose and N-acetylglucosamine (GlcNAc) into N-acetyllactosamine (LacNAc)-enriched galactooligosaccharide (GOS) compositions using novel β-hexosyl-transferase (BHT) enzymes.

First claim

Opening claim text (preview).

What is claimed is: 1 . A functional, recombinant β-hexosyl-transferase (rBHT) polypeptide comprising at least 90% sequence identity with SEQ ID NO: 1 and an N-terminal truncation of 56 amino acids to 81 amino acids in length, with reference to SEQ ID NO: 1. 2 . The polypeptide of claim 1 , wherein the polypeptide comprises at least 95% sequence identity with SEQ ID NO: 1. 3 . The polypeptide of claim 1 , wherein the polypeptide further comprises at least one additional amino acid substitution. 4 . The polypeptide of claim 1 , wherein the polypeptide further comprises a signal sequence. 5 . The polypeptide of claim 4 , wherein the signal sequence comprises an amino acid sequence from a protein from any one of Komagataella ( Pichia ) pastoris, Saccharomyces cerevisiae, Yarrowia lipolytica, Hansenula ( Ogataea ) polymorpha , or Kluyveromyces lactis. 6 . The polypeptide of claim 4 , wherein the signal sequence comprises a polypeptide with at least 90% sequence identity to at least one of α-mating factor signal sequence from Saccharomyces cerevisiae (MFα) (SEQ ID NO: 29), Invertase (IV) signal sequence (SEQ ID NO: 30), Glucoamylase (GA) signal sequence (SEQ ID NO: 31), or Inulinase (IN) signal sequence (SEQ ID NO: 32). 7 . The polypeptide of claim 4 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO: 50, 52, 54, 56, 58, 60, 68, or 70. 8 . The polypeptide of claim 1 , wherein the polypeptide comprises at least one asparagine residue at position 289, 297, 431, or 569 with respect to SEQ ID NO: 1. 9 . The polypeptide of claim 1 , wherein the polypeptide catalyzes the hydrolysis of lactose β-(1-4) glycosidic linkages. 10 . A nucleic acid molecule encoding the polypeptide of claim 1 . 11 . A vector comprising the nucleic acid molecule of claim 10 . 12 . A method of generating a galactooligosaccharide (GOD) composition from lactose in a host cell using the polypeptide of claim 1 . 13 . The method of claim 12 , wherein the GOS composition comprises LacNAc-enriched GOS or GOS lacking GlcNAc. 14 . The method of claim 13 , wherein the host cell is one or more of a yeast cell, a fungal cell, a mammalian cell, an insect cell, a plant cell, or an algal cell. 15 . The method of claim 14 , wherein the host cell comprises one or more cells from Komagataella ( Pichia ) pastoris, Saccharomyces cerevisiae, Yarrowia lipolytica, Hansenula ( Ogataea ) polymorpha , or Kluyveromyces lactis, Aspergillus spp., and Trichoderma reesei. 16 . The method of claim 13 , wherein the method produces a LacNAc-enriched GOS yield of at least 10% of initial lactose concentration, and a total GOS concentration of at least 50% of initial lactose concentration.

Assignees

Inventors

Classifications

  • N-glycosides · CPC title

  • produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins · CPC title

  • Vectors or expression systems specially adapted for eukaryotic hosts · CPC title

  • containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates (indigestible substances A23L33/21) · CPC title

  • produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12559732B2 cover?
The present disclosure provides compositions and methods related to the production of human milk oligosaccharides (HMOs). In particular, the present disclosure provides compositions and methods for converting lactose and N-acetylglucosamine (GlcNAc) into N-acetyllactosamine (LacNAc)-enriched galactooligosaccharide (GOS) compositions using novel β-hexosyl-transferase (BHT) enzymes.
Who is the assignee on this patent?
Univ North Carolina State
What technology area does this patent fall under?
Primary CPC classification C12N9/1051. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).